PMID- 25692400 OWN - NLM STAT- MEDLINE DCOM- 20160127 LR - 20201209 IS - 1557-7600 (Electronic) IS - 1096-620X (Linking) VI - 18 IP - 5 DP - 2015 May TI - Protective Effects of Quercetin Against HgCl(2)-Induced Nephrotoxicity in Sprague-Dawley Rats. PG - 524-34 LID - 10.1089/jmf.2014.3242 [doi] AB - Mercury is a well-known environmental pollutant that can cause nephropathic diseases, including acute kidney injury (AKI). Although quercetin (QC), a natural flavonoid, has been reported to have medicinal properties, its potential protective effects against mercury-induced AKI have not been evaluated. In this study, the protective effect of QC against mercury-induced AKI was investigated using biochemical parameters, new protein-based urinary biomarkers, and a histopathological approach. A 250 mg/kg dose of QC was administered orally to Sprague-Dawley male rats for 3 days before administration of mercury chloride (HgCl2). All animals were sacrificed at 24 h after HgCl2 treatment, and biomarkers associated with nephrotoxicity were measured. Our data showed that QC absolutely prevented HgCl2-induced AKI, as indicated by biochemical parameters such as blood urea nitrogen (BUN) and serum creatinine (sCr). In particular, QC markedly decreased the accumulation of Hg in the kidney. Urinary excretion of protein-based biomarkers, including clusterin, kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemoattractant protein-1 (MCP-1), tissue inhibitor of metalloproteinases 1 (TIMP-1), and vascular endothelial growth factor (VEGF) in response to HgCl2 administration were significantly decreased by QC pretreatment relative to that in the HgCl2-treated group. Furthermore, urinary excretion of metallothionein and Hg were significantly elevated by QC pretreatment. Histopathological examination indicated that QC protected against HgCl2-induced proximal tubular damage in the kidney. A TUNEL assay indicated that QC pretreatment significantly reduced apoptotic cell death in the kidney. The administration of QC provided significant protective effects against mercury-induced AKI. FAU - Shin, Yu Jin AU - Shin YJ AD - 1 College of Pharmacy, Pusan National University , Busan, South Korea . FAU - Kim, Jeong Jun AU - Kim JJ FAU - Kim, Ye Ji AU - Kim YJ FAU - Kim, Won Hee AU - Kim WH FAU - Park, Eun Young AU - Park EY FAU - Kim, In Young AU - Kim IY FAU - Shin, Han-Seung AU - Shin HS FAU - Kim, Kyeong Seok AU - Kim KS FAU - Lee, Eui-Kyung AU - Lee EK FAU - Chung, Kyu Hyuck AU - Chung KH FAU - Lee, Byung Mu AU - Lee BM FAU - Kim, Hyung Sik AU - Kim HS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150218 PL - United States TA - J Med Food JT - Journal of medicinal food JID - 9812512 RN - 0 (Acute-Phase Proteins) RN - 0 (Cell Adhesion Molecules) RN - 0 (Havcr1protein, rat) RN - 0 (Lcn2 protein, rat) RN - 0 (Lipocalin-2) RN - 0 (Lipocalins) RN - 0 (Protective Agents) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Vascular Endothelial Growth Factor A) RN - 53GH7MZT1R (Mercuric Chloride) RN - 9IKM0I5T1E (Quercetin) SB - IM MH - Acute Kidney Injury/chemically induced/*drug therapy/genetics/metabolism MH - Acute-Phase Proteins/genetics/metabolism MH - Animals MH - Cell Adhesion Molecules/genetics/metabolism MH - Humans MH - Kidney/drug effects/metabolism MH - Lipocalin-2 MH - Lipocalins/genetics/metabolism MH - Male MH - Mercuric Chloride/metabolism/*toxicity MH - Protective Agents/*administration & dosage MH - Proto-Oncogene Proteins/genetics/metabolism MH - Quercetin/*pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Vascular Endothelial Growth Factor A/genetics/metabolism OTO - NOTNLM OT - acute kidney injury OT - mercury OT - metallothionein OT - protective effect OT - quercetin EDAT- 2015/02/19 06:00 MHDA- 2016/01/28 06:00 CRDT- 2015/02/19 06:00 PHST- 2015/02/19 06:00 [entrez] PHST- 2015/02/19 06:00 [pubmed] PHST- 2016/01/28 06:00 [medline] AID - 10.1089/jmf.2014.3242 [doi] PST - ppublish SO - J Med Food. 2015 May;18(5):524-34. doi: 10.1089/jmf.2014.3242. Epub 2015 Feb 18.